Ramsay's 'Great Result' Sends Share Price Above 2-Year High
Dow Jones
Aug 27
0511 GMT - Private hospital operator Ramsay Health Care delivered impressive FY26 results across the board, says Jarden analyst Steve Wheen. He was heartened by Ramsay's cost control and operating leverage in Australia. Margin growth of 30 bps in Australia beat consensus, despite the impact of a new funding mechanism affecting its Joondalup public campus in the west. Overall, group Ebit rose by 11.5% and beat consensus by 7.4%. "Outlook for FY27 is similarly bullish, with Ebit growth and margin improvement across both Australia and the U.K.," Jarden says. "Great result." Ramsay is up 13% at A$49.69, representing a more than two-year high.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.